GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SeaSpine Holdings Corp (NAS:SPNE) » Definitions » Gross Margin %

SeaSpine Holdings (SeaSpine Holdings) Gross Margin % : 60.33% (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is SeaSpine Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. SeaSpine Holdings's Gross Profit for the three months ended in Sep. 2022 was $40.5 Mil. SeaSpine Holdings's Revenue for the three months ended in Sep. 2022 was $67.1 Mil. Therefore, SeaSpine Holdings's Gross Margin % for the quarter that ended in Sep. 2022 was 60.33%.


The historical rank and industry rank for SeaSpine Holdings's Gross Margin % or its related term are showing as below:

SPNE' s Gross Margin % Range Over the Past 10 Years
Min: 54.11   Med: 60.83   Max: 63.55
Current: 60.01


During the past 10 years, the highest Gross Margin % of SeaSpine Holdings was 63.55%. The lowest was 54.11%. And the median was 60.83%.

SPNE's Gross Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 53.37 vs SPNE: 60.01

SeaSpine Holdings had a gross margin of 60.33% for the quarter that ended in Sep. 2022 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for SeaSpine Holdings was 1.20% per year.


SeaSpine Holdings Gross Margin % Historical Data

The historical data trend for SeaSpine Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaSpine Holdings Gross Margin % Chart

SeaSpine Holdings Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.68 60.98 63.55 63.17 59.85

SeaSpine Holdings Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.62 53.72 59.81 66.04 60.33

Competitive Comparison of SeaSpine Holdings's Gross Margin %

For the Medical Devices subindustry, SeaSpine Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeaSpine Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SeaSpine Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where SeaSpine Holdings's Gross Margin % falls into.



SeaSpine Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

SeaSpine Holdings's Gross Margin for the fiscal year that ended in Dec. 2021 is calculated as

Gross Margin % (A: Dec. 2021 )=Gross Profit (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=114.6 / 191.451
=(Revenue - Cost of Goods Sold) / Revenue
=(191.451 - 76.864) / 191.451
=59.85 %

SeaSpine Holdings's Gross Margin for the quarter that ended in Sep. 2022 is calculated as


Gross Margin % (Q: Sep. 2022 )=Gross Profit (Q: Sep. 2022 ) / Revenue (Q: Sep. 2022 )
=40.5 / 67.147
=(Revenue - Cost of Goods Sold) / Revenue
=(67.147 - 26.637) / 67.147
=60.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SeaSpine Holdings  (NAS:SPNE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SeaSpine Holdings had a gross margin of 60.33% for the quarter that ended in Sep. 2022 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


SeaSpine Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of SeaSpine Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SeaSpine Holdings (SeaSpine Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5770 Armada Drive, Carlsbad, CA, USA, 92008
SeaSpine Holdings Corp is a medical technology company. The company focuses on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It has orthobiologics and spinal infusion hardware product categories. Its products are anterior and posterior fixation, access systems, bone graft substitutes, and collagen ceramic metrix. The company mainly operates in North America, Europe, Asia-Pacific, and Latin America. It generates revenue by consigning or loaning its products to hospitals and independent sales agents.
Executives
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Beau Standish officer: President, Enabling Tech C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Paul S. Benny officer: VP, Corporate Controller C/O SEASPINE HOLDINGS CORPORATION, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Renee Gaeta director C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Angela Steinway director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Michael Fekete director C/O SAGENT PHARMACEUTICALS, INC., 1901 NORTH ROSELLE ROAD, SUITE 700, SCHAUMBURG IL 60195
Tru St Partnership, L.p. 10 percent owner 795 EAST LANCASTER AVE., STE. 200, VILLANOVA PA 19085
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Richard E Caruso 10 percent owner 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Keith Valentine officer: Chief Executive Officer 7475 LUSK BLVD., SAN DIEGO CA 92121
Kimberly Jo Tzoumakas director 1170 FAIRFAX STREET, BIRMINGHAM MI 48009
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Dennis Cirino officer: Senior VP, Spinal Systems 2361 LOZANA RD, DEL MAR CA 92014
Keith Bradley director
Tyler Lipschultz officer: SVP, Orthobiologics and BD 7475 LUSK BLVD, SAN DIEGO CA 92121